Life Science Company News

Online availability of Sanofi’s half-year financial report for 2021

Online availability of Sanofi’s half-year financial report for 2021


PARIS – July 29, 2021 - Sanofi announces that its half-year financial report for the period ending June 30, 2021 is now available and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the U.S. Securities and Exchange Commission (SEC) under form 6-K.

This document may be found on the company’s corporate website: www.sanofi.com and downloaded from the “Investors” page, under the heading “Regulated Information in France”.

About Sanofi 

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. 

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. 

Media Relations Contacts  
Ashleigh Koss
Tel: +1 (908) 205-2572
Ashleigh.Koss@sanofi.com

Sandrine Guendoul
Tel.: +33 (0)6 25 09 14 25
MR@sanofi.com

Nicolas Kressmann
Tel.: +1 (732) 532-5318
Nicolas.Kressmann@sanofi.com

Investor Relations Contacts Paris 
Eva Schaefer-Jansen 
Arnaud Delepine 
Nathalie Pham 

Investor Relations Contacts North America 
Felix Lauscher 
Fara Berkowitz 
Suzanne Greco  

Tel.: +33 (0)1 53 77 45 45  
investor.relations@sanofi.com 
https://www.sanofi.com/en/investors/contact 

Attachment


By: GlobeNewswire - 29 Jul 2021
Back to overview

Enhance your business development with Biotechgate